Cargando…
Novel cathepsin K inhibitors block osteoclasts in vitro and increase spinal bone density in zebrafish
Cathepsin K (Cat K) is a predominant cysteine protease and highly potent collagenase expressed in osteoclasts. Cat K inhibitors are anti-resorptive agents to treat osteoporosis. A novel scaffold of cathepsin K inhibitors, exemplified by lead compound 1x, was used as the template for designing and sy...
Autores principales: | Xue, Si-tu, Wang, Ya-li, Han, Xiao-wan, Yi, Hong, Jiang, Wei, Si, Shu-yi, Guo, Hui-fang, Li, Zhuo-rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061869/ https://www.ncbi.nlm.nih.gov/pubmed/35518710 http://dx.doi.org/10.1039/c8ra10338k |
Ejemplares similares
-
Knockout and Double Knockout of Cathepsin K and Mmp9 reveals a novel function of Cathepsin K as a regulator of osteoclast gene expression and bone homeostasis
por: Zhu, Guochun, et al.
Publicado: (2022) -
Azanitrile Cathepsin K Inhibitors: Effects on Cell Toxicity, Osteoblast-Induced Mineralization and Osteoclast-Mediated Bone Resorption
por: Ren, Zhong-Yuan, et al.
Publicado: (2015) -
Osteopenia Due to Enhanced Cathepsin K Release by BK Channel Ablation in Osteoclasts
por: Sausbier, Ulrike, et al.
Publicado: (2011) -
Effects of the cathepsin K inhibitor with mineral trioxide aggregate cements on osteoclastic activity
por: Kim, Hee-Sun, et al.
Publicado: (2019) -
Cathepsin K(+) Non-Osteoclast Cells in the Skeletal System: Function, Models, Identity, and Therapeutic Implications
por: Zou, Nanyu, et al.
Publicado: (2022)